EGFR and glioma: Interestingly, TP53, IDH1, CIC, and EGFR occupied the top three positions in the four immune types and thus might be potential mRNA vaccine targets, besides there were interactions among them underlying a variety of tumor-related biological processes in glioma, which indicates that they may be primarily concerned with tumor progression.